Shannon S. Eisenhardt, a director of United Parcel Service Inc, filed a statement of changes in beneficial ownership on November 6, 2026, reporting the acquisition of 918 restricted stock units of UPS Class A common stock on November 4, 2026.
Mark S. Livingston, Chief Financial Officer of Progyny, Inc., filed a Form 4 on November 6, 2026, disclosing the sale of 2,139 shares of common stock on November 4, 2026.
Stacy L. Bogart, SVP and Chief Legal Officer of Winnebago Industries, Inc., filed a Form 4 on November 6, 2026, disclosing stock option exercises and a same-day sale of common shares on November 5, 2026.
Director Jianchang Mao filed an initial statement of beneficial ownership with the SEC on November 6, 2026, disclosing no beneficially owned securities in Criteo S.A. as of the event date of October 28, 2026.
Robert C. Murphy, an officer and director of Snap Inc, filed a Form 144 notice of proposed sale on November 6, 2026, covering 2,000,000 shares of Snap Inc common stock to be sold on NYSE through Wells Fargo Clearing Services.
Maria Olivo, EVP, ERM and Chief Risk Officer of The Travelers Companies, Inc., filed a Form 4 on November 6, 2026, disclosing the sale of 15,000 shares of common stock on November 4, 2026.
Shannon S. Eisenhardt filed an initial statement of beneficial ownership with the SEC on November 6, 2026, disclosing her status as a newly appointed director of United Parcel Service Inc as of November 4, 2026.
Matthew S. Bromberg, an officer and director of Unity Software Inc., filed a Form 144 notice on November 6, 2026, proposing the sale of 100,000 shares of Unity Software common stock on the New York Stock Exchange.
Frontier Group Holdings, Inc. officer Trevor J. Stedke filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 34,180 shares of common stock through UBS Financial Services Inc. on NASDAQ.
The B Kristine Johnson Declaration Trust, affiliated with an AtriCure, Inc. director, filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 2,452 shares of AtriCure common stock on NASDAQ.